Driven by a Mission to Improve Patient Outcomes Through Effective Glycemic Management
As the leader in technology-enabled glycemic management, we’re asked what makes Monarch and the EndoTool Glucose Management System unique.
Certainly, our physiological approach to insulin dosing, exceptional clinical outcomes and seamless interoperability stand out.
However, what truly distinguishes Monarch in the market is our purpose, our vision and our people.
Our Purpose
Our purpose is building and delivering state-of-the-art technology that helps clinicians safely and effectively manage insulin therapy in the inpatient setting.
Our Vision
Our vision is a world without insulin dosing errors.
Our People
Our people are deeply committed to elevating the quality of care for every patient in need of insulin therapy while hospitalized.
Monarch by the Numbers
20
Years of Experience
100+
Health System Clients
7
FDA 510(k) Clearances
1
USPTO Utility Patent
